Viveve Medical, Inc.

VIVE · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$22,027-$21,915-$42,526-$49,981
Dep. & Amort.$1,139$1,297$1,182$786
Deferred Tax-$747$2,312$1,136$179
Stock-Based Comp.$3,779$2,651$2,400$3,035
Change in WC$4,116-$497-$2,337$398
Other Non-Cash$862$918$8,909$2,493
Operating Cash Flow-$12,878-$15,234-$31,236-$43,090
Investing Activities
PP&E Inv.-$456-$781-$1,087-$2,142
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$456-$781-$1,087-$2,142
Financing Activities
Debt Repay.$0$1,343$0$0
Stock Issued$25,826$341$16,274$53,792
Stock Repurch.$0$0$0$0
Dividends Paid$0$0-$378$0
Other Fin. Act.$147$7,546$212$233
Financing Cash Flow$25,973$9,230$16,108$54,025
Forex Effect$0$0$0$0
Net Chg. in Cash$12,639-$6,785-$16,215$8,793
Supplemental Information
Beg. Cash$6,523$13,308$29,523$20,730
End Cash$19,162$6,523$13,308$29,523
Free Cash Flow-$13,334-$16,015-$32,323-$45,232
Viveve Medical, Inc. (VIVE) Financial Statements & Key Stats | AlphaPilot